Gemcitabine, oxaliplatin and dexamethasone as salvage treatment for elderly patients with refractory and relapsed peripheral T-cell lymphoma

Author： Yao Yi-yun   Tang Yong   Zhu Qi   Zhuang Yan   Cheng Yi-min   Wang Lei   Zou Li-fang  

Publisher： Informa Healthcare

ISSN： 1042-8194

Source： Leukemia and Lymphoma, Vol.54, Iss.6, 2013-06, pp. : 1194-1200

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long-term results of gemcitabine plus oxaliplatin with and without rituximab as salvage treatment for transplant-ineligible patients with refractory/relapsing B-cell lymphoma

By Corazzelli Gaetano   Capobianco Gaetana   Arcamone Manuela   Ballerini Pier   Iannitto Emilio   Russo Filippo   Frigeri Ferdinando   Becchimanzi Cristina   Marcacci Gianpaolo   Chiara Annarosaria   Pinto Antonio  

Cancer Chemotherapy and Pharmacology, Vol. 64, Iss. 5, 2009-10 ,pp. : 907-916

Springer Publishing Company

Access to resources Recommend Favorite

Dexamethasone, High-Dose Cytarabine, and Cisplatin in Combination with Rituximab as Salvage Treatment for Patients with Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma

By Mey Ulrich   Orlopp Katjana   Flieger Dimitri   Strehl John   Ho Anthony   Hensel Manfred   Bopp Cordula   Gorschlüter Marcus   Wilhelm Martin   Birkmann Josef   Kaiser Ulrich   Neubauer Andreas   Florschütz Axel   Rabe Christian   Hahn Corinna   Glasmacher Axel   Schmidt-Wolf Ingo  

Cancer Investigation, Vol. 24, Iss. 6, 2006-09 ,pp. : 593-600

Informa Healthcare

Access to resources Recommend Favorite

Bortezomib-based treatment for relapsed and refractory angioimmunoblastic T-cell lymphoma: Case report and literature review

By Liu Shuyan   Yuan Zhengang   Zhang Chunyang   Fu Weijun   Hou Jian  

Oncology Letters, Vol. 4, Iss. 2, 2012-08 ,pp. : 262-264

Spandidos Publications

Access to resources Recommend Favorite

Comparison of ICE (Ifosfamide-Carboplatin-Etoposide) Versus DHAP (Cytosine Arabinoside-Cisplatin-Dexamethasone) as Salvage Chemotherapy in Patients with Relapsed or Refractory Lymphoma

By Abalı Huseyin   Urun Yuksel   Oksuzoğlu Berna   Budakoğlu Burcin   Yıldırım Nuriye   Guler Tunc   Ozet Gulsum   Zengin Nurullah  

Cancer Investigation, Vol. 26, Iss. 4, 2008-05 ,pp. : 401-406

Informa Healthcare

Access to resources Recommend Favorite

Progress in treatment of peripheral T-cell lymphoma with hematopoietic stem cell transplantation

By Zhou Lilan   He Mingsheng  

The Chinese-German Journal of Clinical Oncology, Vol. 10, Iss. 5, 2011-05 ,pp. : 293-296

Springer Publishing Company

Access to resources Recommend Favorite